Browse Data and Analysis

In the past year, there have been no major changes in Kazakhstan’s biotechnology policy. Kazakhstan continues to rely on Eurasian Economic Union (EAEU) regulations for guidance on biotechnology issues.

U.S. exports to Kazakhstan have done well this year, in spite of a variety of obstacles to U.S. exports in Kazakhstan (economic climate, tenge devaluation, transit issues).

There have been few developments in Kazakhstan over the last year with regard to genetically engineered (GE) products. The draft law “On State Regulation of Genetic Engineering Activities” was...